Post-Approval Study of the Neuspera Sacral Neuromodulation System

Launched by NEUSPERA MEDICAL, INC. ·

Keywords

ClinConnect Summary

This clinical trial is studying the long-term safety and effectiveness of the Neuspera Sacral Neuromodulation (SNM) System, a device used to help people who have urinary urgency incontinence—a condition where you suddenly feel a strong need to urinate and may leak urine before reaching the bathroom. The study aims to collect more information about how well the device works and how safe it is after it has already been approved for use.

People who might be eligible for this study are those who have already received the Neuspera SNM device during earlier phases of testing (Phase I or Phase II of a previous study). Both men and women of various ages can participate, but the trial is not yet open for new participants. If you join, you can expect regular check-ups to monitor how the device is working over time and to ensure it remains safe. This study is important because it helps doctors understand the long-term benefits and any potential risks of the Neuspera SNM System for people living with this bladder condition.

Gender

ALL

Eligibility criteria